1. 121 PERIPHERAL BLOOD (PB) WILMS' TUMOR 1 (WT1) EXPRESSION QUANTIFIED BY A STANDARDIZED EUROPEAN LEUKEMIA NET (ELN)-CERTIFIED ASSAY AS PROGNOSTIC AND MINIMAL RESIDUAL DISEASE (MRD) MARKER IN MDS. (April 2015) Authors: Schroeder, T.; Pechtel, S.; Lamers, M.; Dienst, A.; Schuler, E.; Rachlis, E.; Wegener, N.; Kündgen, A.; Kondakci, M.; Fenk, R.; Haas, R.; Germing, U.; Kobbe, G. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 231 UPDATE OF RESPONSE TO TREATMENT WITH AZACITIDINE AND DECITABINE IN HIGH-RISK MDS PATIENTS FROM THE DUESSELDORF MDS REGISTRY – 10 YEARS EXPERIENCE WITH HYPOMETHYLATING TREATMENT. Issue 1 (April 2015) Authors: Neukirchen, J.; Schuck, A.; Götte, M.C.; Kündgen, A.; Kobbe, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 245 CHOICE OF THERAPY HAS THE STRONGEST IMPACT ON SURVIVAL IN OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA OR AML AFTER MYELODYSPLASTIC SYNDROME. Issue 1 (April 2015) Authors: Rumcheva, I.; Schemenau, J.; Hildebrandt, B.; Kündgen, A.; Schroeder, T.; Kondakci, M.; Kobbe, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 264 MMP-9 SERUM LEVEL IN MDS DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION. Issue 1 (April 2015) Authors: Wilk, C.M.; Kündgen, A.; Zilkens, C.; Haas, R.; Krauspe, R.; Germing, U.; Fröbel, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 317 ASXL1 MUTATION IS ASSOCIATED TO LOWER PLATELET COUNTS AND DECREASED BONE MARROW CELLULARITY IN MDS. Issue 1 (April 2015) Authors: Schemenau, J.; Betz, B.; Hildebrandt, B.; Baldus, S.; Kündgen, A.; Neukirchen, J.; Strupp, C.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 318 THE IPSS-R HAS PROGNOSTIC IMPACT IN UNTREATED PATIENTS WITH MDS DEL(5Q). Issue 1 (April 2015) Authors: Schemenau, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Kündgen, A.; Bug, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P532: ACUTE MYELOID LEUKEMIA (AML): UNICENTRIC REPORT ON 1029 PATIENTS DIAGNOSED IN TERTIAL REFERAL CENTER. (23rd June 2022) Authors: Fricke, A.; Nachtkamp, K.; Döhner, K.; Hildebrandt, B.; Betz, B.; Rudelius, M.; Seidl, M.; Zahner, C.; Kobbe, G.; Kündgen, A.; Jäger, P. S.; Baermann, B.-N.; Germing, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P589: AGE AND AGE-ADAPTED RISK FACTORS HIGHLY INFLUENCE SURVIVAL PROBABILITY IN AML PATIENTS – A RETROSPECTIVE ANALYSIS. (23rd June 2022) Authors: Nachtkamp, K.; Zahner, C.; Fricke, A.; Ulrych, T.; Schulz, F. I.; Kündgen, A.; Jäger, P. S.; Kobbe, G.; Germing, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P772: PROGNOSTIC IMPACT OF DISEASE-RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS). (23rd June 2022) Authors: Lesch, C.; Kündgen, A.; Nachtkamp, K.; Kasprzak, A.; Strupp, C.; Rudelius, M.; Gattermann, N.; Kobbe, G.; Hildebrandt, B.; Germing, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups. (April 2017) Authors: Nachtkamp, K.; Reykowski, T.; Hildebrandt, B.; Baldus, S.; Rudelius, M.; Neukirchen, J.; Kündgen, A.; Strupp, C.; Schroeder, T.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗